SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study

Peer Review reports

Original Submission
20 Mar 2022	Submitted	Original manuscript
31 Mar 2022	Author responded	Author comments - Alexandra Dopfer-Jablonka
Resubmission - Version 2
31 Mar 2022	Submitted	Manuscript version 2
Publishing
4 Apr 2022	Editorially accepted
25 Apr 2022	Article published	10.1186/s12879-022-07347-w

Back to article page